{
  "id": "upd-2026-ml9vxyo3",
  "type": "update",
  "status": "applied",
  "createdAt": "2026-02-05T20:04:47.427Z",
  "createdBy": "daemon",
  "reviewedAt": "2026-02-05T20:30:00.000Z",
  "reviewedBy": "claude",
  "appliedAt": "2026-02-05T20:30:00.000Z",
  "rejectionReason": null,
  "testName": "Decipher",
  "testId": null,
  "changes": {
    "newIndication": {
      "indication": "Predicting hormone therapy benefit in men with recurrent prostate cancer",
      "date": null
    }
  },
  "source": "https://investor.veracyte.com/rss/news-releases.xml",
  "sourceTitle": "Veracyte: Decipher expands to Predicting hormone therapy benefit in men with recurrent prostate cancer",
  "confidence": 0.75,
  "snippet": "New indication: Predicting hormone therapy benefit in men with recurrent prostate cancer"
}